Ligand profile
CHEMBL1315592
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_02160 — Phosphoglycerate kinase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1315592- UniProt (similar protein)
Q4GZG4- Target protein
- KP13_02160
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 72.6
- −1 ≤ LogP ≤ 5 3.52
- MW ≤ 500 Da 364.4
- LogP ≤ 5 3.52
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 72.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COC(=O)C1CCN(C(=O)c2cc(-c3ccco3)nc3ccccc23)CC1COC(=O)C1CCN(C(=O)c2cc(-c3ccco3)nc3ccccc23)CC1
InChI=1S/C21H20N2O4/c1-26-21(25)14-8-10-23(11-9-14)20(24)16-13-18(19-7-4-12-27-19)22-17-6-3-2-5-15(16)17/h2-7,12-14H,8-11H2,1H3InChI=1S/C21H20N2O4/c1-26-21(25)14-8-10-23(11-9-14)20(24)16-13-18(19-7-4-12-27-19)22-17-6-3-2-5-15(16)17/h2-7,12-14H,8-11H2,1H3
QEYIUAMGYYGCQT-UHFFFAOYSA-NQEYIUAMGYYGCQT-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Activity
- active
- Binding sites
- PF00162
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1315592 →
- UniProt UniProt Q4GZG4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1315592”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02160.
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).